Show simple item record

dc.contributor.authorNaranjo, Cristina
dc.contributor.authorOrtega Jiménez, Patricia 
dc.contributor.authorDel Reguero, Leticia
dc.contributor.authorMoratalla, Guillermo
dc.contributor.authorFailde Martínez, Inmaculada 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.contributor.otherEstadística e Investigación Operativaes_ES
dc.date.accessioned2025-01-08T13:39:24Z
dc.date.available2025-01-08T13:39:24Z
dc.date.issued2020-07-20
dc.identifier.issn1872-8227
dc.identifier.issn0168-8227
dc.identifier.urihttp://hdl.handle.net/10498/34303
dc.description.abstractObjective To compare cognitive function, mood and sleep status in patients with and without diabetic neuropathic pain (DNP) and their relationship with pain intensity, diabetes complications, and quality of life. To determine whether these relationships differ depending on the sensorial phenotype. Methods Cross-sectional study performed on patients with type-2 diabetes-mellitus and neuropathy. Presence of DNP, pain intensity and phenotype, mood status, sleep characteristics and quality of life were measured. Results A total of 130 patients (65 with DNP) were included. DNP was related to poor sleep quality (OR = 1.03;CI95%:1.02–1.05), pain treatment (OR = 3.00,CI95%:1.24–7.29) or previous anxiety (OR = 2.70,CI95%:1.05–6.99). Patients with specific phenotypes or depression (=0.82,CI95%:−0.02–1.67) referred more severe pain. More complications were related to older age (OR = 1.40,CI95%:1.12–1.66), higher pain intensity (OR = 1.51,CI95%:1.00–2.28), lower cognitive performance (OR = 1.25,CI95%:1.09–1.43), previous anxiety (OR = 10.48,CI95%:1.46–75.24) and insulin treatment (OR = 124.50,CI95%:6.64–2335.06). Decrease in mental quality of life was associated with sleep disorders (β = −0.33,CI95%:−0.48,−0.23), physical comorbidities (β = −9.73,CI95%:−18.15, −1.31) and previous anxiety (β = −7.91,CI95%:−13.04, −2.77). Lower scores in physical quality of life were related to sleep disorders (β = −0.12,CI95%:−0.21, −0.18), obesity (β = −8.35,CI95%:−13.16, −3.55), longer time since diagnosis (β = −0.72,CI95%:−1.44;0.01) and disability (β = −14.58,CI95%:−24.69; −4.48). Conclusions The results support the idea that mental comorbidity and sleep disorders are factors associated with DNP and greater pain intensity, more diabetes complications and lower quality of life. Moreover, they highlight the relationship between sensorial phenotypes and pain intensity, and lower cognitive performance and diabetes complications.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.sourceDiabetes Res Clin Pract. 2020 Jul;165:108236.es_ES
dc.subjectDiabetic neuropathic paines_ES
dc.subjectMental disorderses_ES
dc.subjectSleep disorderses_ES
dc.titleRelationship between diabetic neuropathic pain and comorbidity. Their impact on pain intensity, diabetes complications and quality of life in patients with type-2 diabetes mellitus.es_ES
dc.typejournal articlees_ES
dc.rights.accessRightsclosed accesses_ES
dc.identifier.doi10.1016/j.diabres.2020.108236
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record